MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Xeris Biopharma Holdings, Inc. Common Stock

XERS

#2103
Xeris Biopharma Holdings, Inc. Common Stock
6.12
-5.12%
Sector:
Base:
Profit Currency:
Daily Range
6.12
6.12
Year Range
3.59
10.08
Daily Change
-5.12%
Monthly Change
-17.96%
6 month change
-23.50%
Year Change
+64.08%
Previous Close
6.45
Open
6.12
Bid
Ask
Low
6.12
High
6.12
Volume
141
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. XERS
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 2021202220232024 TTM

News

Investing Investing
XERS
yesterday, 14:37
Xeris Pharmaceuticals faces earnings test as growth accelerates
Benzinga Benzinga
XERS
yesterday, 12:29
Why Are Shares Of Xeris Biopharma Falling Friday? - Xeris Biopharma Holdings (NASDAQ:XERS)
Zacks Zacks
BCRX XERS
2 days ago, 17:15
BioCryst Pharmaceuticals (BCRX) Q4 Earnings and Revenues Surpass Estimates
Investing Investing
XERS
2026.01.07
Xeris Biopharma director Shannon sells $176k in shares
Benzinga Benzinga
NLOP PGR ORI XERS BHVN
2026.01.02
Outlook Therapeutics, Intelligent Bio Solutions And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Biohaven (NYSE:BHVN), Cango (NYSE:CANG)
Investing Investing
CORT XERS
2025.12.31
Xeris Pharmaceuticals stock rises as rival drug faces FDA setback
Investing Investing
NKE CORT SLS TROO VNDA
2025.12.31
NIO, Nike among market cap stock movers on Wednesday
Investing Investing
CORT FCEL VNDA AXSM XERS
2025.12.31
NIO, Xpeng among market cap stock movers on Wednesday
Investing Investing
TEVA CORT XERS
2025.12.31
Jefferies reiterates Buy rating on Xeris Pharmaceuticals stock amid competitor setback
Seeking Alpha Seeking Alpha
XERS
2025.12.18
Xeris Biopharma Stock: A Balanced Perspective Needed (NASDAQ:XERS) (Rating Downgrade)
Investing Investing
XERS
2025.12.02
Hecht Beth, Xeris Biopharma chief legal officer, sells $116k in XERS
Investing Investing
XERS
2025.12.01
Xeris Biopharma receives patent allowance for hypothyroidism drug

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd